7 Best Biotech and Life Sciences PR Agencies in 2027

The best biotech PR agencies understand trial milestones, investor disclosure and the scientific review that every public claim must survive. This guide names seven firms, led by Virgo PR, which publishes the list and has not published a named biotech client case. The order is an editorial choice, not an independent score. Each firm's evidence is attributed to the source that published it.

Disclosure: Virgo PR publishes this guide and appears in it. The selection is not an award, a sponsored ranking or an audited league table. Last reviewed November 5, 2026.

Contents

• What makes a good biotech PR agency?

• How do the seven agencies compare?

• How was the list chosen?

• Who are the seven agencies?

• How should a biotech company choose?

• What does biotech PR cost?

• Which related Virgo PR guides help?

• Frequently asked questions

What makes a good biotech PR agency?

A good biotech PR agency can read a clinical result accurately, explain it without overstating it and coordinate with legal counsel and investor relations. Biotech news moves on trial milestones, regulatory decisions and financings, and a misworded headline can mislead investors or patients. The agency should also be ready for disappointing data, not only good news.

Some firms below focus almost entirely on life sciences. Others are broader healthcare or technology agencies. The evidence for each is stated plainly, and nothing here assumes fees, retainers or contract terms.

How do the seven agencies compare?

RankAgencyBest forEvidence level

1Virgo PREarly-stage and clinical-stage biotech credibilityPublished biotech guides (no named biotech client case published) 2LifeSci CommunicationsMilestone and capital-markets communicationsPublic media tracker naming clients 3Russo PartnersSenior counsel for emerging biotechsClient engagement announcement and sector positioning 4Canale CommunicationsLife science companies heading to public marketsNews report on its life science focus 5Digital ElevatorEarned media with SEO and AI-search supportCase studies it names (agency-reported) 6PAN CommunicationsIntegrated PR with social and contentThird-party listing describing healthcare focus 7BioStrataPR with science writingThird-party listing naming clients

How was the list chosen?

The editorial framework weighed life sciences relevance, named client evidence, knowledge of scientific and business media, senior expertise, published outcomes and commercial transparency. These are evaluation priorities, not computed scores. Public materials are uneven, so each entry says what kind of evidence stands behind it. Results reported by agencies are attributed to them and were not independently audited.

Who are the seven agencies?

1. Virgo PR

Best for: early-stage and clinical-stage biotechs that need science to lead the story.

Virgo PR publishes guidance on how biotech communications should handle trial milestones, investor disclosure and bad data. It has not published a named biotech client case study, so this placement rests on practice focus and published analysis, not client results. Read the nine rules for clinical-stage biotech PR, the overview of biotech and health tech PR and Virgo's healthcare PR agency practice. Ask who on the team would review scientific claims.

2. LifeSci Communications

Best for: development-stage companies running milestone and capital-markets communications.

LifeSci Communications is part of the LifeSci Group, which also includes LifeSci Advisors and LifeSci Capital, and describes itself as a healthcare communications agency serving life sciences companies from pre-clinical development onward. A profile of the firm lists public examples on its media tracker, including Abivax, CAMP4 Therapeutics, Intellia Therapeutics and MeiraGTx. Confirm current clients and scope. Sources: LifeSci profile and company directory entry.

3. Russo Partners

Best for: emerging biotechs that want senior-level counsel.

Russo Partners describes itself as a healthcare and technology communications firm founded in 1988. NervGen, a clinical-stage biotech, announced that it engaged Russo Partners for public relations services. A profile also says the firm published anonymized case studies in March 2026. Ask for references from companies at your stage. Sources: NervGen announcement and Russo Partners profile.

4. Canale Communications

Best for: life science companies preparing for public markets.

A Times of San Diego report describes Canale Communications as a San Diego firm that specializes in serving life science companies, and quotes its leadership on clients that move into public markets and the need for life science investor relations experience. That report is from 2020, so verify the current team and ownership. Source: Times of San Diego.

5. Digital Elevator

Best for: earned media paired with SEO and AI-search work.

Digital Elevator, a West Palm Beach agency founded in 2010 by its own account, names Verseon and Champions Oncology as case study clients and describes PR integrated with SEO and AI search. Its own comparison page ranks itself first, so treat the framing as self-published. Source: Digital Elevator life science guide.

6. PAN Communications

Best for: integrated PR with organic and social support.

The same guide describes PAN Communications as an independent agency founded in 1995 with healthcare and life sciences experience. That is third-party positioning, not a client result, so ask for biotech references. Source: Digital Elevator life science guide.

7. BioStrata

Best for: PR combined with scientific content writing.

The guide lists BioStrata as a Cambridge, UK firm founded in 2014 offering strategy, science writing, digital and PR, with Aptuit and Thermo Fisher named as client examples. Verify those engagements directly. Source: Digital Elevator life science guide.

How should a biotech company choose a PR agency?

• Scientific accuracy. Require a review process in which the company and counsel approve every efficacy, safety and timeline statement.

• Disclosure discipline. Confirm how the agency coordinates with investor relations so material news is released fairly.

• Stage fit. A pre-clinical company, a Phase 2 company and a commercial-stage company need different communications.

• Bad-news readiness. Ask for the agency's plan if a trial misses its endpoint or a regulator delays a decision.

• Contract and staffing. Confirm senior ownership, reporting, minimum term and the cost of milestone-driven bursts of work.

What does biotech PR cost?

This review did not verify comparable public retainers, so no price ranges are stated. Directory ranges vary and are not quotes. Fees depend on stage, team seniority, the number of milestones and whether investor relations work is included. Ask each finalist for a written statement of work covering fees, third-party costs, staffing and cancellation terms.

Which related Virgo PR guides help?

• Clinical-stage biotech PR rules for reading trial milestones.

• Biotech and health tech PR for sector context.

• Best small-cap investor relations firms for listed biotechs.

• Best boutique PR agencies for startups for early-stage companies.

Frequently asked questions

What does a biotech PR agency do?

It helps life sciences companies explain science and business milestones to media, investors, partners and patient communities while respecting regulatory and disclosure limits.

How is biotech PR different from general PR?

Claims about safety, efficacy and timelines are regulated and market-moving, so scientific review and coordination with counsel are essential.

When should a biotech company start PR?

Often before the first major data release or financing, so that the company has a clear narrative and credible spokespeople when news arrives.

Should PR and investor relations be handled together?

They should be coordinated. Material news must reach investors fairly, so the two teams need a shared calendar and approval process.

How should biotech PR be measured?

Track coverage in relevant scientific and business outlets, accuracy of how results are described, and agreed milestones. Coverage does not guarantee a stock or partnering outcome.

Can PR guarantee positive coverage of trial data?

No. Reporters evaluate the data independently. PR can make sure the facts are presented clearly and accurately.

Editorial disclosure and research notes

Virgo PR publishes this guide and appears in it based on its practice focus, not a published client result. Agency results are attributed to their publishers and were not audited. Entries 6 and 7 rest on third-party listings and should be checked with each agency before hiring. Research assembled November 5, 2026.